Related Experiment Videos
[Treatment of hyperthyroidism from Graves-Basedow's disease]
M C López Rey1, M Aguilar Diosdado, A García Curiel
1Departamento de Medicina Interna, Hospital Universitario Puerta del Mar, Facultad de Medicina, Universidad de Cádiz.
Anales De Medicina Interna (Madrid, Spain : 1984)
|May 1, 1993
Summary
Graves' disease treatment outcomes vary. Synthetic antithyroids show lower remission and higher recurrence rates compared to surgery or radioactive iodine for hyperthyroidism management.
Area of Science:
- Endocrinology
- Thyroidology
Context:
- Graves' disease is the leading cause of hyperthyroidism.
- Therapeutic options include antithyroids, radioactive iodine, and surgery.
- Consensus on optimal treatment is lacking.
Purpose:
- To compare the efficacy of synthetic antithyroids, surgery, and radioactive iodine in treating Graves' disease.
- To identify predictors of remission and recurrence in patients treated with antithyroids.
Summary:
- A study analyzed 217 Graves' disease patients: 96 on antithyroids, 46 surgery, 75 radioactive iodine.
- Antithyroid therapy achieved 67% remission, predicted by absence of ophthalmopathy. Recurrence (33/64) predicted by hormone levels.
- Surgery and radioactive iodine controlled hyperthyroidism in 91% and 100% of patients, respectively.
Impact:
- Findings suggest a more aggressive management approach for Graves' disease patients on synthetic antithyroids.
- Highlights the need for individualized treatment strategies based on patient factors and therapeutic outcomes.
- Contributes to understanding long-term efficacy and recurrence patterns of different hyperthyroidism treatments.